Bevacizumab/ranibizumab/triamcinoloneEndophthalmitis: 21 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1377卷 / 1期

关键词：

Patient Outcome; Visual Acuity; Bevacizumab; Congenital Anomaly; Macular Oedema;

D O I：

10.2165/00128415-201113770-00027

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：11 / 11

相关论文

共 50 条

[31] Bevacizumab/ranibizumabOcular hypertension: 10 case reports
Reactions Weekly, 2021, 1877 (1) : 71 - 71
[32] Bevacizumab/irinotecanHepatotoxicity and proteinurea: 2 case reports
Reactions Weekly, 2016, 1618 (1) : 42 - 42
[33] Bevacizumab/irinotecanNeutropenia and mucositis: 2 case reports
Reactions Weekly, 2021, 1871 (1) : 96 - 96
[34] Bevacizumab/dexamethasoneVarious toxicities: 6 case reports
Reactions Weekly, 2020, 1785 (1) : 112 - 112
[35] TriamcinoloneEndophthalmitis following intravitreal administration: case report
Reactions Weekly, 2011, 1347 (1) : 38 - 38
[36] TriamcinoloneEndophthalmitis following intravitreal administration: case report
Reactions Weekly, 2010, 1322 (1) : 30 - 30
[37] Bevacizumab/cyclophosphamideVarious toxicities: 5 case reports
Reactions Weekly, 2023, 1950 (1) : 92 - 92
[38] Bevacizumab/TemozolomideLack of efficacy: 2 case reports
Reactions Weekly, 2024, 2030 (1) : 98 - 98
[39] Aflibercept/bevacizumab/ranibizumabEndophthalmitis: 15 case reports
Reactions Weekly, 2023, 1950 (1) : 21 - 21
[40] Bevacizumab/oxaliplatinVarious toxicities: 10 case reports
Reactions Weekly, 2011, 1365 (1) : 10 - 10

← 1 2 3 4 5 →